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Abstract. 1-Phenyl-3-(p-methoxypheny1)- and 1,3-di(p-methoxypheny1)dihydro-2- 
thioxo-4,6 (1 H, 5H)-pyrimidinediones have been synthesised and coupled with different 
diazotised simple and sulphonamide bases to furnish the corresponding 5-(arylazo/N- 
substituted p-sulphamy1benzeneazo)dihydro-2-thioxo-461, 5H)-pyrimidinediones. 
On in vitro screening these were found to exhibit considerable activity against a number 
of micro-organisms. 
Introduction 
In view of the importance of dihydro-2-thioxo-4,6(1H, 5H)-pyrimidinediones in 
therapy and textile industry1 and encouraged by the results obtained during the course of 
earlier work on the synthesis and screening of arylazo pyrimidinediones2, it was 
thought of interest to synthesise some new pyrimidinedione congeners having the 
methoxyl group in one or both the phenyl rings attached at positions 1 and 3 of the 
pyrimidine nucleus since the presence of the methoxyl group has been reported to 
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enhance the activity considerably in arylazo azoles3. This work would provide an 
opportunity to study the effect of replacement of halogen and alkyl groups by an alkoxyl 
on the antibacterial properties, their comparison with the earlier work, thus establish- 
ing the structure activity relationship. 
The present paper describes the synthesis of 1-phenyl-3-(p-methoxypheny1)- and 
1,3-di(p-methoxypheny1)dihydro-2-thioxo-46(H 5H)-pyrimidinediones and their 
coupling with diazotised simple and sulphonamide bases to yield 1-phenyl-3-(p- 
methoxypheny1)- and 1,3-di(p-methoxypheny1)-5-(arylazo/N-substituted p-sulphamyl- 
benzeneazo)dihydro-2-thioxo-4,6(1H, 5H)-pyrimidinediones of the type as shown in 
Figure 1 (a, b). The homogeneity and purity of these compounds were checked by 
TLC and elemental analysis and structure assigned on the basis of IR and NMR 
spectral studies. 
Experimental 
Synthesis of l-phenyl-3-(p-methoxyphenyl)dihydro-2-thioxo-4,6(1H, 5H)-pyrimidine- 
diones 
Acetyl chloride (15 ml) was added to a mixture of 1-phenyl-3-(p-methoxypheny1)- 
thiourea (10.4g; 0.04 mol) and malonic acid (4.268; 0.041 mol) contained in a R.B. 
flask (100 ml) and the contents refluxed on a water bath for 30 minutes. The reaction 
mixture on cooling and treating with water solidified to a yellow coloured mass which 
was broken and finally powdered in a mortar in presence of water. The heavy solid was 
filtered, washed first with water and then with hot ethanol; pure 1-phenyl-3-(p-methoxy- 
phenyl)dihydro-2-thioxo-4,6(1H, 5H)-pyrimidinedione was crystallised from glacial 
acetic acid as a yellow solid, m.p. 173-4 "C. (Yield: 7.3g; 55.6 %). 
KBR: 1687, (Found: C, 62.1; H, 4.9. C,,H,,N,O,S requires C, 62.2; H, 4.9 %). IR v max 
1695 cmdl(> C = 0); 103 1 cm-I (> C = S); 1333 cm-1 (-CAN) and 8 13,826 cm-l 
I1 
s 
(1 ,Csubstituted phenyl). 
NMR (TFA) : 3-p-OCH, (3.456, S, 3H); -COCH,CO- (3.758, S, 2H) and aromatic 
protons (6.65-7.06, m, 9H) .  
1,3-Di(p-methoxypheny1)dihydro-2-thioxo-46 H 5H)-pyrimidinedione was similarly 
prepared and crystallised from glacial acetic acid as a pale yellow solid, m.p. 202 "C. 
(Yield : 60.0%). 
K B R :  1701, Found :'C, 60.7; H, 4.4. Cl8H,,O,N,S requires C, 60.7; H, 4.5%). IR v max 
1724 cm-1 (> C = 0); 103 1 cm-1 (> C = S); 1333 cm-I (-C-N) and 820 cm-I 
I1 
S 
(1, 4-substituted phenyl). 
NMR (CDCI, i TFA) : 1 and 3-p-OCHa (3.98, S, 6H); --COCH,CO-(3.26, S, 2H) 
and aromatic protons (7.156, unresolved singlet, 8H). 
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The NMR spectrum (DMSO) of 1-(p-methoxypheny1)-3-phenyl- and 1,3-di- 
(p-methoxypheny1)thioureas show a singlet due to NH protons at 10.708 and 10.528 
respectively which is absent in the NMR spectra (DMSO) of the two pyrimidinediones 
thereby confirming its cyclic structure which is further supported by the absence of any 
band due to NH group in the region 3100-3300 cmn-I in the IR spectrum of these 
compounds. 
Synthesis of l-phenyl-3-(p-methoxyphenyl)-5-(arylazo/N-substituted p-sulphamyl- 
benzeneazo)dihydro-2-thioxo-4,6(1 H, 5H)-pyrimidinediones 
A diazotised solution of the base (0.0015 mol) was gradually added to a well cooled, 
rnechanically stirred solution of I-phenyl-3-(p-methoxypheny1)dihydro-2-thioxo-4,6 
(lH, 5H)-pyrimidinediones (0.001 5 mol) in dioxane-ethanol mixture containing sodium 
acetate (2g). The reaction mixture was further stirred for 5 min. and the solid separated 
on addition of ice-cold water was filtered, dried and crystallised from DMF-ethanol 
mixture. 
Similar set of reactions was carried out with 1,3-di(p-methoxypheny1)dihydro-2- 
thioxo-4,6(1H, 5H)-pyrin~idinediones and all the synthesised compounds have been 
recorded in Table 1-4. 
The IR spectra of the synthesised azo compounds showed bands at 1689-1739 cm-l 
(doublet) (> c ='o), 1026-103 1 cm-l (>C=S), 1333 cm-l (-CAN), 1587-1600 
II 
S 
cm-1 (N = N) and 813-833 cm-l (1,4-substituted phenyl). In the case of 5-(N-substi- 
tuted p-sulphamylbenzeneazo)derivatives bands at 1087 and 1266 cm-I are characteristic 
of S = 0 symmetric and unsymmetric vibrational modes, while bands at 3350-3400 cm-l 
may be due to NH group. 
The azo structure has also been confirmed by NMR spectral studies. In the case 
of 5-arylazo analogues, there is no hump or peak due to NH or OH protons. The CH 
protons of position 5 move downfield and merge with aromatic protons due to the 
presence of three electron attracting groups around it. 
Different 1,3-diaryl-5-(arylazolN-substituted p-sulphamy1benzeneazo)dihydro-2- 
thioxo-4,6(1H, 5H)-pyrimidinediones when subjected to in vitro screening at two 
different concentrations of 50 pg/ml and 100 pg/ml against S.  aureus, E. coli and P. 
pyocyanea showed promising results. 
The activity of the compounds synthesised by coupling 1-phenyl-3-(p-methoxypheny1)- 
dihydro-2-thioxo-4,6(1 H, 5H)-pyrimidinediones with simple and sulphonamide bases, 
against three micro-organism is in the order of P. pyocyanea > S. aureus > E. coli. 
It was further observed that the introduction of a methoxyl group in the phenyl ring 
attached at position-3 as in 1,3-di(p-methorypheny1)-analogues renders the compound 
less active against all the three micro-organisms which is in conformity with our earlier 
findings4; however, the sequence of order of activity against the three strains is the same. 
It was further observed that the azo derivatives synthesised from sulphonamide 
bases were more active as compared to those prepared from simple bases against all 
the three micro-organisms. 
Table 1. l-~hen~l-3-(p-methox~~henyl)-5-(arylazo)dih~dro-2-thioxo-4,6(1~, 5H)-pyrimidinediones 
(Fig. l a  : X = H, R = C,H4Rf) 2 &? 
Percentage 3 
S. No. R' M.P. Colour Yield Crystallisation Molecular b 
("c) ( %) solvent formula Found Requires % 
C H C H 
1 H 288 Y 74 DMFIEtOH CZ~HI,NJ&S 64.1 4.2 64.2 4.2 
2 o-Methyl 282 0 71 DMFIEtOH C Z ~ H Z O N ~ O , ~  64.8 4.4 64.9 4.5 
3 m-Met hy 1 252 0 69 DMF/EtOH Cz4HzoN4OaS 64.6 4.4 64.9 4.5 
4 p-Methyl 289 R 72 DMF/EtOH C Z ~ H Z O N ~ O ~ S  64.5 4.3 64.9 4.5 
5 o-Chloro 292 0 76 DMFiEtOH C S ~ H I ~ N ~ O ~ S C I  59.4 3.7 59.5 3.7 
6 m-Chloro 233 B 75 DMFjEtOH C ~ J ~ I ~ N ~ O ~ S C I  59.5 3.6 59.5 3.7 
7 p-Chloro 275 R 79 DMF/EtOH C2dfl7N40,ScI 59.2 3.6 59.5 3 7 
8 o-Bromo 274 0 79 DMF/EtOH CZ3Hl,N403SBr 54.1 3.1 54.2 3.3 
9 p-Bromo 23 1 B 80 DMF/EtOH C ! ~ I ~ N ~ O ~ S B ~  54.2 3.1 54.2 3.3 
10 o-Nitro 267 B 78 DMF/EtOH C Z ~ H I ~ N # $  58.0 3.6 58.1 3.6 
11 m-Nitro 239 B 80 DMFIEtOH C Z ~ H I , N ~ O , S  58.1 3.5 58.1 3.6 
12 p-Nitro 171 B 79 DMF/EtOH CZ~HI,N~O,S 57.9 3.5 58.1 3.6 
13 o-Melhoxy 289 BY 74 DMF/EtOH C ~ J ~ ~ O N ~ O ~ S  62.4 4.2 62.6 4.3 
14 m-Methoxy 254 B 72 DMF/EtOH C Z , H Z O N ~ O ~ S  62.1 4.3 62.6 4.3 
15 p-Methoxy 132 Y 74 DMF/EtOH CZ&ZON~O~S 62.5 4.3 62.6 4.3 
16 2.5-Dichloro 287 B 80 DMFIEtOH c ~ 3  HI ,N~O~SCIZ 55.3 3.1 55.4 3.2 
Table 2. I-Phenyl-3-(p-methoxypheny1)-5-(N-substituted p-sulphamylbenzeneazo)dihydro-2-thioxo-41 H, 5Hl-pyrimidinediones 
(Fig. l b  : X = W; R = C,H,SO,NHR') 
S. No. R' M.P. Colour Yield 
("(2 (%) 
Crystallisation 
solvent 
Molecular 
formula 
H >300 
Acetyl 28 2 
Phenyl 306 
o-Methylphenyl 177 
m-Methylphenyl 296 
p-Methylphenyl 263 
o-Chlorophenyl 160 
p-Bromophenyl 244 
o-Methoxyphenyl 251 
p-Ni~rophenyl 261 
Guanidyl 276 
Pyrimidin-2-yl 205 
2,6-Dimethyl- 
pyrimidin-4-yl 170 
4,dDimethyl- 
pyrimidin-2-yl 115 
4-Methyl- 
pyrimidin-2-yl 189 
Thiazol-2-yl 182 
3-Methoxy- 
pyrizin-6-yl 186 
1-Phenyl- 
pyrazol-4-yl 245 
Percentage 
- s s Found Requires 3 
C H C H  9 
% 54.1 3.7 54.2 3.7 % 
54.2 3.7 54.4 3.8 2 
59.5 3.6 59.5 3.9 
60.0 4.2 60.1 4.2 2 ;=: 
60.1 4.1 60.1 4.2 0 
60.1 4.0 60.1 4.2 
56.0 3.3 56.0 3.5 8 
52 0 3.5 2 52.2 3.6 5 
58.1 4.0 58.0 4.1 & 
55.1 3.5 55.2 3.5 
52.1 3.7 52.3 3.8 2 
55.1 3.6 55.2 3.6 7 
55.6 4.1 55.9 4.0 
=: 
55.9 4.0 55.9 4.0 * 
Table 3. 1,3-Bis(p-methoxyphenyl)-5-(arylazo)dihydro-2-thioxo-4,6(1 H, 5H)-pyrimidinediones 
(Fig. la  : X = p-OCH, ; R = C,H,R') 2 & 
Percentage rp 
R ' Colour Yield .u S. No. M.P. Crystallisation Molecular ("c) (%I solvent formula Found Requires 
C H C H 
BL 
Grey 
B 
B 
B 
BL 
B 
B 
BL 
BL 
B 
BL 
BL 
BL 
B L 
Table 4. 1 ,3-Bis(p-methoxyphenyl)-5-(N-substituted p-sulphamy1benzenea~o)dihydro-2-thioxo-46 H, 5H)-pyrimidinediones 
(Fig. Ib : X = p-OCH,; R = C6H4SOzNHR') 
-- - -- 
Percentage 
S. No. R ' M.P. Colour Yield Crystallisation Molecular 
("c) (%) solvent formula Found Requires 
C H c H 3  
H 185 BL 68 GAA/EtOH C ~ ~ H Z ~ O ~ N ~ S ,  53.3 3.8 53.4 3.9 3 
Acetyl 171 BL 69 DMF/EtOH CZ~HZIO.IN~S, 53.6 4.0 53.7 4.0 3 
Phenyl 265 B 65 GAA/EtOH C3oHz5O~N5S2 58.4 4.0 58.5 4.1 
o-Methylphenyl 184 B 65 GAA/EtOH C ~ I H ~ ~ O ~ N ~ S ,  59.0 4.2 59.1 4.3 s: 
111-Methylphenyl 215 BL 63 DMF/EtOH c3,Hz70e.N5S~ E 59.1 4.2 59.1 4.3 2 
p-Methylphenyl 272 0 68 GAA/EtOH ~ z , H ~ ~ O ~ N ~ S ,  59.0 4.1 59.1 4.3 
0-Chlorophenyl 244 B 69 DMFlEtOH c a a H ~ 4 O ~ N ~ S ~ c ~  55.8 3.6 55.9 3.7 % 
lit-Chlorophenyl 259 R 67 DMF/EtOH C,OH,,O~N,S~CI 55 7 3.5 55.9 3.7 
0-Methoxyphenyl 241 0 67 GAA/EtOH C ~ ~ H Z , O ~ N ~ S ~  57.4 4.2 57.7 4.2 
p-Nitrophenyl 205 B 7 1 GAA/EtOH C ~ O H Z ~ O S N ~ S ~  54.3 3.3 54.5 3.6 
Guanidyl > 300 0 68 DMF/EtOH C*~HZ,O~NS 51.5 4.0 51.6 4.0 % 
P 
Pyrimidin-2-yl 182 B 72 GAA/EtOH C Z S H Z ~ O ~ N J  54.3 3.5 54.4 3.7 
2,6-Dimethyl 216 BO 69 GAA/EtOH caoHz,O,NrS 55.7 4.0 55.8 4.2 
pyrimidin-4-yl % 
4,6-Dimethyl 194 B 74 GAA/EtOH caoHz,OoNS 55.6 4.1 55.8 4.2 9 
pyrimidin-2-yl I 
15 2,6-Dimerhoxy 228 0 71 GAA/E tOH caaHz7o,N7s 53.1 4.0 53.2 4.0 2 
pyrimidin-4-yl 
16 4-Methyl 204 0 72 GAAlEtOH C29H2506N7S 5 55.0 3.8 55.1 4.0 2 
pyrimidin-2-yl 
17 3-Methoxy 274 Y 67 GAA!EtOH c29HZ607N7S2 54.3 3.8 54.6 3.9 
pyrazin-6-yl 
18 1-Phenyl 169 B 69 GAA/EtOH C ~ , H ~ O G N &  58.0 3.9 58.1 4.0 
pyrazol-4-yl 
19 Thiazol-2-yl 214 B 72 DMF/EtON Ca7H2z0,N6s~ 55.7 5.2 55.9 5.3 
20 5-Methyl-1,3,4- >300 0 74 DMFlEtOH C~,HZ~O~N.IS,  50.5 3.7 50.8- 3.8 
thiadiazol-2-yl 
GAA = Glacial acetic acid; DMF = Dimethylformamide 
B = Brown; BL = Black; 0 = Orange; Y = Yellow f2 

